CME Presentations

Migraine

Presentations

Speakers

  • Stewart Tepper, MD

    Stewart Tepper, MD

    Stewart Tepper, MD

    Professor of Neurology

    Stewart J. Tepper, MD, FAHS, is a professor of neurology at the Geisel School of Medicine at Dartmouth College in Hanover, and director of the Dartmouth Headache Center in the Department of Neurology of Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Dr Tepper has published more than 430 peer-reviewed manuscripts, editorials, and books on headache medicine. He is editor-in-chief of the journal, Headache Currents, and associate editor for the journal, Headache. Dr Tepper serves on the executive board of directors for the American Headache Society and the American Migraine Foundation. He received his medical degree from Cornell University Medical College in New York, New York.

    Session Appearances

    Updates on Calcitonin Gene-Related Peptide-Targeted Therapies for Acute and Chronic Migraine

  • Susan Hutchinson, MD

    Susan Hutchinson, MD

    Susan Hutchinson, MD

    Director

    Susan L. Hutchinson, MD, is director and founder of Orange County Migraine & Headache Center in Irvine, California. She is also on the Volunteer Faculty Department in the Department of Family Medicine at UC-Irvine Medical Center. Dr Hutchinson concentrates on the management of migraine and mood disorders with a special interest in the relationship of both conditions to hormones. In recent years, she has co-authored numerous journal articles and chapters about migraine. Dr Hutchinson served as chair of the Women’s Issues Section of American Headache Society from 2005-2010 and is president of the Headache Cooperative of the Pacific. She was selected as a Physician of Excellence by the Orange County Medical Association in January 2007.

    Session Appearances

    Updates on Calcitonin Gene-Related Peptide-Targeted Therapies for Acute and Chronic Migraine

    Learn About an Anti-CGRP mAb for Migraine Prevention

CME Information

Updates on Calcitonin Gene-Related Peptide-Targeted Therapies for Acute and Chronic Migraine

Einstein LogoMontefiore Logo PQH Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Summarize the underlying pathophysiology of CGRP and its role in the development of migraine
  • Assess the relative safety and efficacy of CGRP targeted agents (monoclonal antibodies and small antagonist) for the treatment of acute and chronic migraine
  • Contrast CGRP monoclonal antibodies and small molecule antagonist for migraine against traditional treatment options used to treat migraine
  • Identify clinician barriers to optimal management of migraine
  • Describe the clinical consequences of nonadherence in patients with migraine and how they may be adequately addressed
Presented by the Albert Einstein College of Medicine-Montefiore Medical Center in Joint Providership with PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This educational activity is supported by an educational grant from Allergan.

TUITION

Complimentary

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and PlatformQ Health Education, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CREDIT DESIGNATION STATEMENTS

Live Internet Activity

Albert Einstein College of Medicine-Montefiore Medical Center designates this internet live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine-Montefiore Medical Center designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

DATE OF RELEASE/EXPIRATION

Live Internet Activity

Friday, January 22, 2021 from 3:00 PM EST – 4:00 PM EST

Enduring Material

The enduring material will be available from January 22, 2021 to January 22, 2022.

INTENDED AUDIENCE

This activity is intended for neurologists, headache specialists, primary care physicians, pain specialists, psychiatrists, nurse practitioners, physician assistants, nurses, OB-GYNs, and pharmacists.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™ participants must receive a minimum score of 70% on the posttest.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter Disclosures
Stewart J. Tepper, MD
Professor of Neurology
Geisel School of Medicine at Dartmouth 		Grants for research: Allergan, Amgen, ElectroCore, Eli Lilly, Lundbeck, Neurolief, Novartis, Satsuma, Zosano
Consultant and/or Advisory Boards: Aeon, Allergan/Abbvie, Amgen, Aralez Pharmaceuticals Canada, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, CoolTech, Currax, Eli Lilly, Impel, Lundbeck, Neurolief, Nordic BioTech, Novartis, Pulmatrix, Relevale, Satsuma, Teva, Theranica, XOC, Zosano
Susan Hutchinson, MD
Director
Orange County Migraine & Headache Center 		Consultant and/or Advisory Boards: Alder/Lundbeck, Allergan/Abbvie, Amgen, Biohaven, Currax, electroCore, Lilly, Novartis, Teva, Theranica, Upsher-Smith
Speaker’s Bureau: Allergan/Abbvie, Amgen, Biohaven, electroCore, Lilly, Lundbeck, Novartis, Teva, Theranica, Upsher-Smith
Peer Reviewer Disclosures
David M. Kaufman, MD Has nothing to disclose relevant to this activity.
PlatformQ Health Education, LLC Disclosures
Carole Drexel, Medical Director Has nothing to disclose relevant to this activity.
Jaimee Harris-Gold, Program Manager Has nothing to disclose relevant to this activity.


CONTACT INFORMATION

Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

For issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine-Montefiore Medical Center, NeuroSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.